Challenge
A $60B biopharma lacked cohesive launch governance and execution ahead of two major product introductions, risking disjointed execution across global teams.
Approach
Scimitar created an agile launch execution team staffed by empowered cross-functional leaders, instituted rapid-cycle design sprints, and developed a five-stage governance framework with clear decision gates. Best practices were codified in a comprehensive playbook to ensure future scalability.
Impact
The launch execution team enabled flawless launches for two $2B+ blockbusters, achieving 20% cost savings and ahead-of-schedule delivery. The new model became the company standard for high-stakes launches.